Michael E. Jung


title: "Michael E. Jung" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["university-of-california,-los-angeles-faculty", "21st-century-american-chemists", "living-people", "rice-university-alumni", "columbia-university-alumni", "1947-births"] topic_path: "society/education" source: "https://en.wikipedia.org/wiki/Michael_E._Jung" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::data[format=table title="Infobox person"]

FieldValue
nameMichael E. Jung
image{{CSS image crop
ImageJung_Michael_2016.jpg
bSize300
cWidth190
cHeight200
oTop21
oLeft55
Locationcenter
captionJung in 2016
birth_date
birth_placeNew Orleans
occupationProfessor
::

| name = Michael E. Jung | image = {{CSS image crop |Image = Jung_Michael_2016.jpg |bSize = 300 |cWidth = 190 |cHeight = 200 |oTop = 21 |oLeft = 55 |Location = center |Description = | alt = | caption = Jung in 2016 | birth_date = | birth_place = New Orleans | nationality = | occupation = Professor | years_active = | known_for = | notable_works =

Michael E. Jung is a Professor of Chemistry in the Department of Chemistry and Biochemistry at the University of California at Los Angeles.

Michael Jung was born May 14, 1947, in New Orleans, Louisiana.

Early life and education

Jung received a B.A. from Rice University in Houston, Texas, in 1969 and a Ph.D. from Columbia University in New York City in 1973 where he did research with Gilbert Stork.

Career

::figure[src="https://upload.wikimedia.org/wikipedia/commons/d/d1/Oxetanocin_A.svg" caption="Oxetanocin A"] ::

::figure[src="https://upload.wikimedia.org/wikipedia/commons/3/30/Halomon3D.png" caption="[[Halomon"] ::

::figure[src="https://upload.wikimedia.org/wikipedia/commons/a/ae/Enzalutamide-01.svg" caption="[[Enzalutamide"] ::

Jung then obtained a NATO Postdoctoral Fellowship to work with Albert Eschenmoser at the Eidgenössische Technische Hochschule in Zürich, Switzerland. In 1974, he joined the faculty at UCLA, where he has spent his career. In 1979 Jung was awarded a Sloan research fellowship.

Jung's research is focused on the development of new reactions for organic synthesis, including the Jung "non-aldol aldol" protocol, an alternate method for obtaining aldol products without using the classical aldol reaction. He has also developed chemical syntheses for a variety of natural products with antitumor and antiviral properties including tedanolides, oxetanocin, halomons, and xestobergsterol. Other research interests include the bridged Robinson annulation and the mixed Lewis acid Diels-Alder process. ::figure[src="https://upload.wikimedia.org/wikipedia/commons/1/11/Apalutamide.svg" caption="Apalutamide"] ::

Jung's research group developed an antagonist of the androgen receptor enzalutamide, which is a pharmaceutical drug used for the treatment of hormone refractory prostate cancer. An analog of enzalutamide, apalutamide, was also FDA approved.

Awards

References

References

  1. [http://www.chem.ucla.edu/~jung/CV.html UCLA, Department of Chemistry and Biochemistry]
  2. "Past Fellows".
  3. [http://www.chem.ucla.edu/dept/Organic/Jung_Brochure.html Research Interests], Organic Chemistry Faculty, UCLA
  4. (January 2008). "Synthesis of the C1–C12 fragment of the tedanolides. Selective hydroboration–protonation of allylic alcohol approach". Tetrahedron Letters.
  5. (February 2001). "Synthesis of a Fully Functionalized Protected C1−C11 Fragment for the Synthesis of the Tedanolides". Organic Letters.
  6. (December 2000). "Use of the non-aldol aldol process in the synthesis of the C1–C11 fragment of the tedanolides: use of lactol ethers in place of tetrahydrofurans". Tetrahedron Letters.
  7. (October 1996). "Highly stereoselective synthesis of trans,trans-4-aryl-2,3-oxetanedimethanols: Preparation of oxetanocin a analogues". Tetrahedron Letters.
  8. (1 October 1997). "Synthesis of Several Naturally Occurring Polyhalogenated Monoterpenes of the Halomon Class1". The Journal of Organic Chemistry.
  9. (February 2001). "First total synthesis of xestobergsterol A and active structural analogues of the xestobergsterols". Tetrahedron.
  10. [http://www.chem.ucla.edu/~jung/research.html Current Research Interest], UCLA
  11. "New Prostate Cancer Agent Class: Rational design leads to novel drug candidate, now in clinical trials", ''[[Chemical and Engineering News]]'', September 22, 2008, Volume 86, Number 38 pp. 84-87
  12. [http://www.chemistry.ucla.edu/news/item?item%5fid=43116 UCLA Chemistry and Biochemistry]
  13. "UCLA Glenn T. Seaborg Symposium - Previous Recipients".
  14. (24 March 2016). "2015 Michael E. Jung, UCLA".
  15. "AACR Team Science Award".
  16. "Arthur C. Cope Scholar Awards".

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::

university-of-california,-los-angeles-faculty21st-century-american-chemistsliving-peoplerice-university-alumnicolumbia-university-alumni1947-births